Leandro Fórnias Machado de Rezende1, Melina Arnold2, Fabiana Maluf Rabacow3, Renata Bertazzi Levy4, Rafael Moreira Claro5, Edward Giovannucci6, José Eluf-Neto4. 1. Departamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: lerezende@usp.br. 2. International Agency for Research on Cancer, Section of Cancer Surveillance, Lyon, France. 3. Universidade Católica Dom Bosco, Campo Grande, Brazil; Universidade Anhanguera Uniderp, Campo Grande, Brazil. 4. Departamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. 5. Department of Nutrition, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. 6. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States.
Abstract
BACKGROUND: Body mass index (BMI) has been constantly increasing over the last decades in most parts of the world, most notably in transitioning nations such as Brazil. High BMI (>22 kg/m2) is associated with an increased risk of 14 types of cancer. We estimated the extent to which reducing high BMI could lower cancer incidence in Brazil, nationally as well as at regional and state levels. METHODS: We calculated fractions of cancer incidence in 2012 attributable to high BMI as well as projections for attributable cases in 2025 using BMI data from representative national surveys and relative risks published in meta-analyses. Estimates of cancer incidence were retrieved from GLOBOCAN and the Brazilian National Cancer Institute. RESULTS: We found that 15,465 (3.8%) of all new cancer cases diagnosed in Brazil in 2012 were attributable to high BMI, with a higher burden in women (5.2%) than in men (2.6%). The cancer sites contributing most to the number of attributable cases were breast (n = 4777), corpus uteri (n = 1729), and colon (n = 681) in women, and colon (n = 1062), prostate (n = 926), and liver (n = 651) in men. The highest population attributable fractions (PAFs) for all cancers were found in the richer states of the country, located in the south (1.5% men/3.4% women) and the southeast (1.5% men/3.3% women). CONCLUSIONS: Cancer cases attributable to high BMI will reach 29,490, which will be 4.6% of all cancers in Brazil in 2025; the extent will be greater in women (6.2% or 18,837) than in men (3.2% or 10,653). This information is a tool to support policy makers for future cancer prevention strategies in Brazil.
BACKGROUND: Body mass index (BMI) has been constantly increasing over the last decades in most parts of the world, most notably in transitioning nations such as Brazil. High BMI (>22 kg/m2) is associated with an increased risk of 14 types of cancer. We estimated the extent to which reducing high BMI could lower cancer incidence in Brazil, nationally as well as at regional and state levels. METHODS: We calculated fractions of cancer incidence in 2012 attributable to high BMI as well as projections for attributable cases in 2025 using BMI data from representative national surveys and relative risks published in meta-analyses. Estimates of cancer incidence were retrieved from GLOBOCAN and the Brazilian National Cancer Institute. RESULTS: We found that 15,465 (3.8%) of all new cancer cases diagnosed in Brazil in 2012 were attributable to high BMI, with a higher burden in women (5.2%) than in men (2.6%). The cancer sites contributing most to the number of attributable cases were breast (n = 4777), corpus uteri (n = 1729), and colon (n = 681) in women, and colon (n = 1062), prostate (n = 926), and liver (n = 651) in men. The highest population attributable fractions (PAFs) for all cancers were found in the richer states of the country, located in the south (1.5% men/3.4% women) and the southeast (1.5% men/3.3% women). CONCLUSIONS:Cancer cases attributable to high BMI will reach 29,490, which will be 4.6% of all cancers in Brazil in 2025; the extent will be greater in women (6.2% or 18,837) than in men (3.2% or 10,653). This information is a tool to support policy makers for future cancer prevention strategies in Brazil.
Authors: Leandro F M Rezende; Thainá Alves Malhão; Rafael da Silva Barbosa; Arthur Orlando Correa Schilithz; Ronaldo Corrêa Ferreira da Silva; Luciana Grucci Maya Moreira; Paula Aballo Nunes Machado; Bruna Pitasi Arguelhes; Maria Eduarda Leão Diogenes Melo Journal: BMC Public Health Date: 2022-06-21 Impact factor: 4.135
Authors: Leandro F M Rezende; Eliana Murata; Beatriz Giannichi; Luciana Yuki Tomita; Gabriela Arantes Wagner; Zila M Sanchez; Carlos Celis-Morales; Gerson Ferrari Journal: BMC Cancer Date: 2020-07-25 Impact factor: 4.430
Authors: Ronaldo Corrêa Ferreira da Silva; Luciana Ribeiro Bahia; Michelle Quarti Machado da Rosa; Thainá Alves Malhão; Eliane De Paula Mendonça; Roger Dos Santos Rosa; Denizar Vianna Araújo; Luciana Grucci Maya Moreira; Arthur Orlando Correa Schilithz; Maria Eduarda Leão Diogenes Melo Journal: PLoS One Date: 2021-03-11 Impact factor: 3.240
Authors: José Matheus Estivaleti; Juan Guzman-Habinger; Javiera Lobos; Catarina Machado Azeredo; Rafael Claro; Gerson Ferrari; Fernando Adami; Leandro F M Rezende Journal: Sci Rep Date: 2022-07-26 Impact factor: 4.996
Authors: Ricardo Riquelme; Leandro F M Rezende; Juan Guzmán-Habinger; Javiera L Chávez; Carlos Celis-Morales; Catterina Ferreccio; Gerson Ferrari Journal: Sci Rep Date: 2021-07-29 Impact factor: 4.379